Ms Lee’s journey at Novartis began as a Nanyang Polytechnic intern in 2015. After joining the company full-time in 2021, she quickly left her mark – leading a project focused on autoimmune diseases and working with healthcare providers to come up with a way to help more patients get treatment.
Now, as an SSO study start up manager, she oversees the start up of clinical trials and contributes to the smooth running of clinical trial operations globally.
Her bachelor’s degree in life sciences and master’s degree in pharmaceutical science and technology, both from the National University of Singapore, had already given her a strong foundation and an edge in clinical research. Her deep technical know-how and strong interpersonal skills also makes her stand out.
“Being recognised at the global level is both humbling and motivating,” she says.
Her achievement highlights the strength of the Singapore office’s role in global clinical trials. With strong support from other departments like Regulatory Affairs and Legal, the local ecosystem plays an instrumental role in enabling timely trial start up and execution. “It takes a village to accelerate clinical trials,” Ms Lee says.
“This award belongs to everyone who has been part of this journey,” she adds, highlighting Novartis Singapore’s commitment to nurturing home-grown talent.
PhD holder thrives in an ‘unbossed’ culture
Since joining the company in 2022, Novartis Singapore’s “unbossed” culture has given Dr Esdy Rozali the autonomy and trust to take initiative, make decisions and pursue ideas without being micromanaged.
“We’re not measured by the number of hours spent at the desk, but by the impact and value we bring to our roles,” he says.
As a medical lead, he helps connect scientific research with real-world medical practice. He studies the latest data on treatments, identifies gaps in patient care, and works with doctors and healthcare teams to develop medical plans.